Company intelligence / Profile preview

Natulab

Ownership: Private
Employees: ~646
Development stage: Other

Overview

Natulab is one of Brazil’s largest manufacturers of over-the-counter medications, herbal medicines, and vitamin supplements. The company has a portfolio exceeding 150–160 products across multiple therapeutic areas. All manufacturing complies with ANVISA standards. Recent years saw acquisition activity due to internal fraud issues but the business remains active under new ownership.

Therapeutic areas: NeurologyMetabolic DisordersPsychiatryPulmonologyDermatologyGastroenterologyCardiovascularImmunologyWomen's Health
Modalities: Small moleculeHerbal medicineVitamin supplementHomeopathic product
Industry: Food & Nutrition

Beyond the preview

Go deeper on Natulab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natulab.

Explore the full profile